Eric C. Strain

Eric C. Strain's work focuses on addiction medicine, particularly opioid use disorder, opioid withdrawal, and treatments such as buprenorphine and suvorexant. His research also extends into emerging areas like psychedelic-assisted therapy (psilocybin and MDMA) for depression and PTSD, as well as broader substance use treatment access, stigma, and clinical trial methodology. Prospective students would be working in an area that bridges clinical pharmacology, addiction treatment research, and evidence synthesis methods.

Publication output has been fairly steady over the last decade, averaging about 9-11 papers per year, with a peak around 2023 and a slight decline in the most recent years (2024-2026, though 2026 data may be incomplete).

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026